SCHEMBL30936621

SCHEMBL30936621

C[Si](C)(C)CCOCOc1ccccc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 2/20 0.42
USP2 O75604 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
MAOA P21397 1/20 0.40
HTR2B P41595 1/20 0.40
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
TP53 P04637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FFAR1 O14842 1/20 0.38
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29265162 0.87 ALOX5AP (0.36) ALDH1A1NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL2135396 0.85 TSHR (0.34) ALDH1A1NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL7466903 0.81 AR (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL9476261 0.79 PLCG1 (0.35) ALDH1A1NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL20607680 0.79 NPC1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL24538043 0.76 HTR7 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL34475296 0.76 HTR7 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL22588118 0.76 ALDH1A1 (0.50) ALDH1A1KDM4EADRA2BGAA
SCHEMBL10112340 0.76 ALOX5AP (0.35)
SCHEMBL29910054 0.76 TSHR (0.36) ALDH1A1NPC1RAB9AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630420-A1 INHIBITORS OF NLRP3 F. Hoffmann-La Roche AG (CH) 2025-10-15 EP disclosed
WO-2024121184-A1 INHIBITORS OF NLRP3 F. HOFFMANN-LA ROCHE AG (CH) 2024-06-13 WO disclosed